These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29206383)

  • 21. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tumor cells: clinical validity and utility.
    Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
    Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications.
    Tjensvoll K; Nordgård O; Smaaland R
    Int J Cancer; 2014 Jan; 134(1):1-8. PubMed ID: 23447365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells.
    Chen JY; Chang YC
    Adv Exp Med Biol; 2017; 994():43-66. PubMed ID: 28560667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells in lung cancer.
    Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
    Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm].
    Chinese Pathologic Consensus Group for Gastrointestinal and Pancreatic Neuroendocrine Neoplasm
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):257-62. PubMed ID: 21616002
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.
    De Mattos-Arruda L; Olmos D; Tabernero J
    Future Oncol; 2011 Dec; 7(12):1385-97. PubMed ID: 22112315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
    Kim JY; Hong SM
    Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated and circulating tumor cells in gastrointestinal oncology.
    Bidard FC; Ferrand FR; Huguet F; Hammel P; Louvet C; Malka D; Boige V; Ducreux M; Andre T; de Gramont A; Mariani P; Pierga JY
    Crit Rev Oncol Hematol; 2012 May; 82(2):103-15. PubMed ID: 21680197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers.
    Sclafani F; Smyth E; Cunningham D; Chau I; Turner A; Watkins D
    Clin Colorectal Cancer; 2014 Jun; 13(2):94-9. PubMed ID: 24332356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of CTCs as Tumor Biomarkers.
    Lianidou ES; Markou A; Strati A
    Adv Exp Med Biol; 2015; 867():341-67. PubMed ID: 26530376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
    Ardill JE; O'Dorisio TM
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cells in pancreatic cancer patients: efficacy in diagnosis and value in prognosis.
    Xie ZB; Yao L; Jin C; Fu DL
    Discov Med; 2016 Sep; 22(120):121-128. PubMed ID: 27755967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma.
    Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK
    J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
    Detjen KM; Rieke S; Deters A; Schulz P; Rexin A; Vollmer S; Hauff P; Wiedenmann B; Pavel M; Scholz A
    Clin Cancer Res; 2010 Jan; 16(2):420-9. PubMed ID: 20068079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
    Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
    Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.